Pesquisas alternativas:
dose » dos (Expandir a Pesquisa)
devel » level (Expandir a Pesquisa), devem (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
devel » level (Expandir a Pesquisa), devem (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
1
Por Park, Gab-jin, Bae, Soo Hyeon, Park, Wan-Su, Han, Seunghoon, Park, Min-Ho, Shin, Seok-Ho, Shin, Young G, Yim, Dong-Seok
Publicado no Drug Des Devel Ther (2017)
“...PURPOSE: A microdose drug–drug interaction (DDI) study may be a valuable tool for anticipating drug...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Norris, Susan L, Zhang, Xuanping, Avenell, Alison, Gregg, Edward, Schmid, Christopher H, Lau, Joseph
Publicado no Cochrane Database Syst Rev (2005)
“... of data on other drugs for weight loss or control in persons with type 2 diabetes....”Publicado no Cochrane Database Syst Rev (2005)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Cascini, Fidelia, Farcomeni, Alessio, Migliorini, Daniele, Baldassarri, Laura, Boschi, Ilaria, Martello, Simona, Amaducci, Stefano, Lucini, Luigi, Bernardi, Jamila
Publicado no Plants (Basel) (2019)
“...Genetic markers can be used in seeds and in plants to distinguish drug-type from fiber-type...”Publicado no Plants (Basel) (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Lee, Jieon, Rhee, Su-jin, Lee, SeungHwan, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2018)
“... dose or as multiple doses to healthy Caucasians. METHODS: Thirty-six subjects were enrolled...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Galmarini, C M, Kamath, K, Vanier-Viornery, A, Hervieu, V, Peiller, E, Falette, N, Puisieux, A, Ann Jordan, M, Dumontet, C
Publicado em 2003
“... derived from the human breast adenocarcinoma MCF-7 containing either the wild-type p53 (wt-p53; MN1) or a...”Publicado em 2003
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Gilardini, Luisa, Redaelli, Gabriella, Croci, Marina, Conti, Antonio, Pasqualinotto, Lucia, Invitti, Cecilia
Publicado no Obes Facts (2016)
“... loss < 5%). Age, gender, whole and central obesity, concomitance of type 2 diabetes, chronic renal...”Publicado no Obes Facts (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Ammoun, Sylwia, Schmid, Marei Caroline, Triner, Joceline, Manley, Paul, Hanemann, Clemens Oliver
Publicado em 2011
“...Loss of the tumor suppressor merlin is a cause of frequent tumors of the nervous system...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... with drug-induced reaction. DESIGN: A 54-year-old patient was presented with Stevens-Johnson syndrome after...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Trindade-da-Silva, Carlos Antonio, Bettaieb, Ahmed, Napimoga, Marcelo Henrique, Lee, Kin Sing Stephen, Inceoglu, Bora, Ueira-Vieira, Carlos, Bruun, Donald, Goswami, Sumanta Kumar, Haj, Fawaz G., Hammock, Bruce D.
Publicado no J Pharmacol Exp Ther (2017)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... with the administration of crushed tablets, including the potential for inaccurate dosing and reduced rate of absorption...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Huang, Ji-Han, Su, Qian-Min, Yang, Juan, Lv, Ying-Hua, He, Ying-Chun, Chen, Jun-Chao, Xu, Ling, Wang, Kun, Zheng, Qing-Shan
Publicado no Drug Des Devel Ther (2015)
“..., in the earlier phases of drug research and development, there are a variety of designs for dosage investigational...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... tubule. Dapagliflozin, an SGLT2 inhibitor, targets hyperglycaemia in type 2 diabetes by increasing renal...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Blakeley, Jaishri O., Ye, Xiaobu, Duda, Dan G., Halpin, Chris F., Bergner, Amanda L., Muzikansky, Alona, Merker, Vanessa L., Gerstner, Elizabeth R., Fayad, Laura M., Ahlawat, Shivani, Jacobs, Michael A., Jain, Rakesh K., Zalewski, Christopher, Dombi, Eva, Widemann, Brigitte C., Plotkin, Scott R.
Publicado no J Clin Oncol (2016)
“...PURPOSE: Neurofibromatosis type 2 (NF2) is a tumor predisposition syndrome characterized...”Publicado no J Clin Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Michelangelo Paci, Simona Casini, Milena Bellin, Jari Hyttinen, Stefano Severi
Publicado em 2018-11-01
Assuntos:
“...induced pluripotent stem cell-derived cardiomyocyte...”Publicado em 2018-11-01
Obter o texto integral
Artigo
15
Por Jung, Jin Ah, Kim, Tae-Eun, Lee, Hyun, Jeong, Byeong-Ho, Park, Hye Yun, Jeon, Kyeongman, Kwon, O Jung, Ko, Jae-Wook, Choi, Rihwa, Woo, Hye-In, Koh, Won-Jung, Lee, Soo-Youn
Publicado no Drug Des Devel Ther (2015)
“... hepatotoxicity. The objective of this study was to develop an individualized INH dosing regimen using a...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Yoshihito Ishida, Hideshi Kawakami, Hiroyuki Kitajima, Ayaka Nishiyama, Yoshiki Sasai, Haruhisa Inoue, Keiko Muguruma
Publicado em 2016-11-01
Assuntos:
“...spinocerebellar ataxia type 6...”Publicado em 2016-11-01
Obter o texto integral
Artigo
17
Por Subramaniam, Menaga, Liew, Su Ki, In, Lionel LA, Awang, Khalijah, Ahmed, Niyaz, Nagoor, Noor Hasima
Publicado no Drug Des Devel Ther (2018)
“... of the same death mechanism with reduced dosage of each drug could potentially be clinically beneficial...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... is useful, convenient, and highly selective. The phenylalanine derivatives tested are of a novel type...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“..., was formulated as gastroretentive dosage form (GRDF) tablets to enhance its oral bioavailability. GRDF tablets...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Baumgart, Meike, Luder, Kerstin, Grover, Shipra, Gätgens, Cornelia, Besra, Gurdyal S, Frunzke, Julia
Publicado em 2013
“...BACKGROUND: The development of new drugs against tuberculosis and diphtheria is focused...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo